Condition: Knee Cartilage Lesions · Sponsor: Nanochon, Inc.
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
This description comes directly from the study's public registry record.
Chief Clinical Officer · 615-483-7438 · Heather@Nanochon.com
Always discuss trial participation with your own doctor first.
| University of British Columbia | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| Orthopaedic Clinic | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07249489